Skip to main content

Table 4 Prescription cost per patient-year for all diabetes-related medications (€PY)

From: Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study

 

2006

2012

p

Glucose-lowering (all patients)

390.7 [363.5-418.0]

612.4 [586.5-638.2]

< 0.001

Glucose-lowering (only treated patients)

405.3 [377.6-433.1]

621.1 [595.1-647.1]

< 0.001

 OAD only

324.9 [297.0-352.9]

504.5 [476.3-532.7]

< 0.001

 Insulin

553.8 [501.6-606.0]

763.8 [720.6-807.0]

< 0.001

 Excluding incretins

405.3 [501.6-606.0]

508.0 [474.7-541.3]

< 0.001

 Excluding incretins & adjusting for insulin analog use

442.4 [415.2-469.6]

463.2 [431.5-495.0]

0.34

Antihypertensive (all patients)

285.3 [270.6-300.1]

255.2 [241.1-269.2]

0.004

Antihypertensive (only treated patients)

371.5 [356.0-387.1]

318.7 [304.7-332.7]

< 0.001

Lipid-lowering (all patients)

357.3 [335.0-379.5]

361.0 [339.9-382.1]

0.81

Lipid-lowering (only treated patients)

571.8 [547.2-596.4]

449.9 [429.5-450.3]

< 0.001

Antiplatelet (all patients)

89.0 [75.8-102.1]

78.1 [65.6-90.7]

0.25

Antiplatelet (only treated patients)

169.8 [146.2-193.4]

146.4 [124.2-168.5]

0.16

Total

1122.3 [1078.1-1166.5]

1306.7 [1264.6-1348.7]

< 0.001

  1. Data are shown as mean [95% CI]. Treated patients are considered as those receiving the respective class of medication. All comparisons have been adjusted for age and duration of diabetes.